Address

OrbiMed Advisors LLC
767 Third Avenue
30th Floor
New York, NY 10017
United States

Open Map

Business classification

VCID: 29979
    Profile
    Founders

    Corporate information

    Official name
    OrbiMed Advisors Limited Liability Company

    Registration country
    Investment activity status
    Active investor

    Company type

    American investment firm focused on making public and private investments in the healthcare and biotechnology industries.

    Overview

    OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through a range of private equity funds, public equity funds, and royalty/credit funds. OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and extensive global team resources to help build world-class healthcare companies. OrbiMed’s team of over 100 professionals is based in New York City, San Francisco, Shanghai, Hong Kong, Mumbai, Herzliya, and other key global markets.

    Current employees

    [node:title] photo Nissim Darvish

    Investment preferences

    Investment focus themes

    Selected investments

    Country Date Notes
    Blossomhill Therapeutics Inc
    Biotechnology company focused on oncology and autoimmune disorders.
    United States 4 Mar 2021 Series A
    Initial investment. Round participant. Active
    Armo BioSciences Inc
    Late-stage immuno-oncology company.
    1 Sep 2017 Series C-1
    Follow-on investment. Round participant. Active
    Nutrinia Ltd
    Developer of an oral formulation of insulin for intestinal malabsorption in preterm newborns and SBS in infants.
    Israel 18 Aug 2016 Series D
    Follow-on investment. Round participant. Active
    Tricida Inc
    United Kingdom 4 Mar 2015
    4 Sep 2014
    15 Jul 2016
    Series C
    Follow-on investment. Round participant. Active
    Natera Inc
    Biotechnology company providing preconception and prenatal genetic testing services.
    United States 1 May 2013 Venture
    Initial investment. Led the investment round. Active
    Acceleron Pharma Inc
    Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases.
    United States 1 Dec 2009
    1 Dec 2011
    1 Jun 2010
    Series F
    Initial investment. Round participant. Active
    Cleave Biosciences Inc
    Drug development company focused on novel targets in cellular protein homeostasis pathways
    United States 1 Oct 2011 Series A
    Active
    Ambit Biosciences Inc
    A biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer.
    United States 10 Jun 2011 Series D
    Complete Genomics Inc
    United States 1 Aug 2009
    1 Aug 2010
    Series E
    Active
    Selecta Biosciences Inc
    A biotechnology company developing a new class of synthetic nanoparticle vaccines.
    United States 5 Apr 2010 Series C
    Adimab LLC
    Developer of a human antibody discovery platform in yeast.
    United States 1 Oct 2009 Series D
    Active
    Amnis Corp
    A biotechnology company developing high throughput laboratory automation tools that use a novel molecule detection technology.
    United States 1 Jul 2009 Series D
    ARYx Therapeutics Inc
    United States 1 Nov 2008 N/A
    Initial investment. Round participant. Active
    Biolex Therapeutics Inc
    United States 1 Oct 2008 Series D
    Active
    Innovative Spinal Technologies Inc
    Spine technology company.
    United States 8 Sep 2008 Series C

    DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.